Betapam 5 mg Tablet.
PDF Leaflet Revision Date: 19 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of anxiety, muscle relaxation, and pre-operative medication.
Dosage (summary)
Initial: 5-10 mg; Usual: 5-20 mg daily; Max single: 10 mg.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; may cause floppy-infant syndrome. Avoid in breastfeeding.
Key Drug Interactions
- Alcohol
- CNS depressants
- Anticonvulsants
Contraindications
- Hypersensitivity to benzodiazepines
- Severe respiratory insufficiency
- Severe hepatic insufficiency
- Sleep apnoea syndrome
- Myasthenia gravis
Common side effects
- Drowsiness
- Confusion
- Fatigue
- Ataxia
Counselling Points
- Avoid alcohol and CNS depressants
- Do not operate heavy machinery
- Treatment duration should be limited
Serious warnings
- Risk of dependence and withdrawal symptoms
- Caution in patients with a history of substance abuse
- May cause anterograde amnesia
Important Disclaimer
The Betapam 5 mg Tablet. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
